Compare GRFS & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | M |
|---|---|---|
| Founded | 1940 | 1830 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.8B |
| IPO Year | N/A | 2000 |
| Metric | GRFS | M |
|---|---|---|
| Price | $7.99 | $17.10 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 12 |
| Target Price | $10.15 | ★ $20.70 |
| AVG Volume (30 Days) | 699.4K | ★ 6.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.77% | ★ 4.24% |
| EPS Growth | N/A | ★ 444.74 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $23,006,000,000.00 |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $6.50 | N/A |
| P/E Ratio | ★ $18.67 | $35.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.19 | $9.76 |
| 52 Week High | $11.14 | $24.41 |
| Indicator | GRFS | M |
|---|---|---|
| Relative Strength Index (RSI) | 33.76 | 31.80 |
| Support Level | $7.64 | $16.48 |
| Resistance Level | $9.11 | $18.06 |
| Average True Range (ATR) | 0.28 | 0.70 |
| MACD | -0.09 | -0.19 |
| Stochastic Oscillator | 15.85 | 8.96 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.